NOVEL USE OF QUINAZOLINONE COMPOUND FOR THE TREATMENT OF CANCER
F. Hoffmann-La Roche AG
Filing date: 4 Nov, 2021
Application n./ Patent N: 212063336.6
ICREA selects researchers based solely on their scientific achievements. However, excellent science often leads to the invention of new and amazing technologies and solutions. When that happens, ICREA fully supports the exploitation of these opportunities.
Our ICREA research professors are working in different Universities and Research Centres. On account of this, ownership of any intellectual or industrial property is always shared between ICREA and the host institution. To make negotiations as fast and conclusive as possible, host institutions are entitled to explore and engage in technology transfer activities on behalf of ICREA when opportunities arise. ICREA supports the exploitation efforts and offers advice throughout the process.
Please have a look at our current technologies and contact ICREA to learn more about them.
F. Hoffmann-La Roche AG
Filing date: 4 Nov, 2021
Application n./ Patent N: 212063336.6
ICN2
Filing date: 30 Sep, 2021
EP21382884.1 / PCT/EP2022/077073
IDIBAPS
Filing date: 20 Aug, 2021
EP21382772.8
Filing date: 28 May, 2021
Licenced date: 28 May, 2021
US2022380882 (A1)
Filing date: 30 Apr, 2021
21-0584-EP
VHIO
Filing date: 21 Apr, 2021
Licenced date: 23 Dec, 2021
EP21382343.8
ICIQ
Filing date: 15 Apr, 2021
Licenced date: 26 Apr, 2022
EP20382294
ICFO and ICREA
Filing date: 22 Mar, 2021
EP20383093.0
Filing date: 19 Mar, 2021
PCT/EP2021/057122
Filing date: 29 Jan, 2021
PCT/EP2021/052110